Abstract
ObjectivesThe study (206347) compared organ damage progression in patients with systemic lupus erythematosus (SLE) who received belimumab in the BLISS long-term extension (LTE) study with propensity score (PS)-matched patients treated...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have